BridgeMD
New treatment option for Preoperative Anxiety
Official title Anxiety, Physiological Parameters, Patient Satisfaction and VR in Gynecological Oncology Surgery
ClinicalTrials.gov ID: NCT07016880
What this study is testing
- What it's testing
- Surgical procedures often cause significant anxiety in patients, particularly among women undergoing gynecological oncology surgeries. Preoperative anxiety is a common and preventable condition that can negatively affect both physiological parameters and the overall surgical experience.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older, women only
You may be able to join if
- The participant must have a confirmed diagnosis of gynecological cancer.
- The participant must be aware of their gynecological cancer diagnosis.
- Participants must be 18 years of age or older.
- Verbal and written informed consent to participate in the study must be obtained.
- The participant must be able to communicate verbally and in writing in Turkish.
You likely can't join if
- History of recurrent gynecological cancer.
- Presence of vision problems that prevent the use of VR goggles, including participants who wear glasses or have uncorrected vision impairment.
- Presence of conditions such as migraines, vertigo, active nausea, vomiting, or frequent headaches.
- Sensitivity to motion sickness.
- Diagnosis of a psychiatric condition, whether under pharmacological or non-pharmacological treatment.
- Withdrawal of consent during the study.
See the full eligibility criteria
- The participant must have a confirmed diagnosis of gynecological cancer.
- The participant must be aware of their gynecological cancer diagnosis.
- Participants must be 18 years of age or older.
- Verbal and written informed consent to participate in the study must be obtained.
- The participant must be able to communicate verbally and in writing in Turkish.
- No communication impairments (e.g., visual, auditory, or cognitive) should be present.
- This must be the participant's first surgical intervention related to gynecological oncology.
- Eastern Cooperative Oncology Group (ECOG) Performance Status must not exceed 2.
- The planned surgical procedure must be a laparotomy.
- History of recurrent gynecological cancer.
- Presence of vision problems that prevent the use of VR goggles, including participants who wear glasses or have uncorrected vision impairment.
- Presence of conditions such as migraines, vertigo, active nausea, vomiting, or frequent headaches.
- Sensitivity to motion sickness.
- Diagnosis of a psychiatric condition, whether under pharmacological or non-pharmacological treatment.
- Withdrawal of consent during the study.
- Removal of the virtual reality headset during the intervention.
- Development of any medical complications during the intervention period.
The study team makes the final eligibility decision.
Where it's taking place
- Ankara, Turkey (Türkiye)
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Ankara, Turkey (Türkiye). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.